Paul Sobiech, PA
Physician Assistant · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 12 years
- Graduated 2014
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Paul Sobiech’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence G61255 · Deceased
Licence status: Deceased · since 1987 · University of California San Francisco School of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$8,417
Medicare paid this office $8,417 for 231 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| External shock to heart to regulate heart beat | 32 | $2,654 | $80 |
| Programming of dual lead pacemaker system | 90 | $2,467 | $27 |
| Programming of dual lead implantable defibrillator system | 23 | $971 | $40 |
| Programming of multiple lead implantable defibrillator system | 13 | $549 | $42 |
| Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | 31 | $471 | $11 |
See all 7 services
| External shock to heart to regulate heart beat | 32 | $2,654 | $80 |
| Programming of dual lead pacemaker system | 90 | $2,467 | $27 |
| Programming of dual lead implantable defibrillator system | 23 | $971 | $40 |
| Programming of multiple lead implantable defibrillator system | 13 | $549 | $42 |
| Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | 31 | $471 | $11 |
| Programming of multiple lead pacemaker system | 12 | $408 | $31 |
| Programming of single lead pacemaker system | 13 | $306 | $24 |
Who their Medicare patients are
231 Original Medicare patients in 2024. Average age 77 · Under 65 6% · 85 and older 20% · Women 45% · Also on Medicaid 28% · Health risk score 2.60. Sicker patients than 9 in 10 peers; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Atrial fibrillation 75% · Heart failure 69% · Coronary heart disease 64% · Chronic kidney disease 53% · Diabetes 48% · Cancer 25% · Depression 25% · Stroke 22% · COPD 20% · Dementia 13%.
The office billed $534,373, Medicare allowed $10,909 and paid $8,417; for 255 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 231 | 255 | 77 | 2.60 | $534,373 | $8,417 |
| 2023 | 18 | 19 | 75 | 1.36 | $255,230 | $1,513 |
| 2022 | 198 | 471 | 77 | 1.79 | $91,499 | $15,217 |
| 2021 | 277 | 699 | 77 | 1.60 | $137,979 | $26,433 |
| 2020 | 290 | 767 | 76 | 1.91 | $152,721 | $28,049 |
| 2019 | 371 | 797 | 77 | 1.99 | $167,027 | $30,767 |
| 2018 | 208 | 292 | 76 | 2.05 | $78,950 | $15,800 |
| 2017 | 88 | 229 | 69 | 1.56 | $23,174 | $6,215 |
| 2016 | 88 | 278 | 63 | 1.38 | $25,418 | $7,638 |
| 2015 | 105 | 361 | 64 | 1.32 | $31,303 | $9,773 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| External shock to heart to regulate heart beat | 17 | $1,506 | $84 |
2022: 5 services
| Return visit (30+ min) | 137 | $11,564 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $1,397 | $47 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 126 | $1,232 | $8 |
| Blood test, clotting time | 30 | $166 | $4 |
| Insertion of needle into vein for collection of blood sample | 38 | $122 | $3 |
2021: 7 services
| Return visit (30+ min) | 214 | $21,916 | $76 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 193 | $2,203 | $9 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $676 | $40 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $197 | $15 |
| Blood test, clotting time | 34 | $190 | $4 |
| Insertion of needle into vein for collection of blood sample | 44 | $147 | $3 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 11 | $98 | $9 |
2020: 9 services
| Return visit (30+ min) | 211 | $19,420 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $2,901 | $48 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 197 | $2,672 | $11 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $712 | $47 |
| Short return visit (20+ min) | 11 | $610 | $51 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $346 | $12 |
| External ekg recording for more than 48 hours up to 21 days | 14 | $286 | $20 |
| Blood test, clotting time | 31 | $195 | $4 |
| Insertion of needle into vein for collection of blood sample | 30 | $92 | $3 |
2019: 7 services
| Return visit (30+ min) | 220 | $20,598 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $5,852 | $47 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 159 | $2,255 | $11 |
| External ekg recording for more than 48 hours up to 21 days | 21 | $423 | $20 |
| Programming of dual lead pacemaker system | 21 | $335 | $16 |
| Blood test, clotting time | 36 | $231 | $4 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $221 | $14 |
2018: 3 services
| Return visit (30+ min) | 129 | $11,367 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $3,027 | $48 |
| Programming of dual lead pacemaker system | 11 | $190 | $16 |
2017: 2 services
| Short return visit (20+ min) | 47 | $2,570 | $40 |
| Return visit (30+ min) | 23 | $1,811 | $70 |
2016: 4 services
| Return visit (30+ min) | 50 | $2,945 | $55 |
| Short return visit (20+ min) | 40 | $2,506 | $43 |
| Bacterial colony count, urine | 11 | $129 | $11 |
| Insertion of needle into vein for collection of blood sample | 15 | $85 | $3 |
2015: 6 services
| Return visit (30+ min) | 67 | $4,628 | $60 |
| Short return visit (20+ min) | 40 | $2,580 | $44 |
| X-ray of chest, 2 views, front and side | 17 | $173 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 11 | $166 | $10 |
| Insertion of needle into vein for collection of blood sample | 17 | $94 | $3 |
| Manual urinalysis test with examination using microscope, automated | 17 | $76 | $4 |
Medicaid work
$2,576 in 2021
Medicaid paid $2,576 for 50 billed services this clinician did in 2021, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 25 | $2,300 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 25 | $276 |
| 2021 | 50 | 2 | 12 | $2,576 |
Drugs they prescribed that Part D paid
$13,051
Pharmacies billed $13,051 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
102 generic and 24 brand-name prescriptions · $13,051 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 19 | $9,511 | $501 |
| Dofetilide | 21 | $1,877 | $89 |
| Amiodarone | 20 | $392 | $20 |
Year by year
| 2024 | 126 | 60 | None | 19% | $13,051 |
| 2023 | 600 | 235 | None | 22% | $172,475 |
| 2022 | 4,375 | 675 | 0% (0) | 18% | $1,014,509 |
| 2021 | 4,257 | 728 | 0% (0) | 17% | $764,163 |
| 2020 | 3,330 | 620 | None | 17% | $409,932 |
| 2019 | 3,213 | 588 | 0% (0) | 17% | $290,944 |
| 2018 | 2,154 | 447 | None | None | $175,249 |
| 2017 | 419 | 140 | None | 20% | $14,774 |
| 2016 | 419 | 144 | 5% (21) | 14% | $17,407 |
| 2015 | 452 | 161 | 10% (44) | None | $12,471 |
| 2014 | 63 | 32 | None | None | $1,119 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Eliquis | 82 | $110,843 | $1,352 |
| Xarelto | 31 | $38,448 | $1,240 |
| Metoprolol | 79 | $2,516 | $32 |
| Dofetilide | 11 | $1,760 | $160 |
| Atorvastatin | 48 | $1,441 | $30 |
| Torsemide | 42 | $1,206 | $29 |
| Rosuvastatin | 28 | $849 | $30 |
| Sotalol | 32 | $649 | $20 |
| Diltiazem 24hr Er (Cd) | 13 | $526 | $40 |
| Amlodipine Besylate | 29 | $345 | $12 |
| Losartan | 19 | $332 | $17 |
| Lisinopril | 17 | $214 | $13 |
| Carvedilol | 15 | $207 | $14 |
2022: 41 drugs
| Eliquis | 555 | $673,164 | $1,213 |
| Xarelto | 136 | $176,396 | $1,297 |
| Entresto | 24 | $28,453 | $1,186 |
| Metoprolol | 687 | $23,842 | $35 |
| Rosuvastatin | 249 | $9,526 | $38 |
| Flecainide Acetate | 85 | $7,600 | $89 |
| Torsemide | 298 | $7,232 | $24 |
| Atorvastatin | 295 | $5,736 | $19 |
| Diltiazem 24hr Er (Cd) | 67 | $4,256 | $64 |
| Amiodarone | 89 | $3,927 | $44 |
| Potassium Chloride | 70 | $3,888 | $56 |
| Sotalol | 149 | $3,538 | $24 |
| Lisinopril | 223 | $3,255 | $15 |
| Mexiletine | 15 | $2,560 | $171 |
| Losartan | 165 | $2,336 | $14 |
| Isosorbide Mononitrate Er | 69 | $1,981 | $29 |
| Amlodipine Besylate | 135 | $1,583 | $12 |
| Bumetanide | 22 | $1,573 | $72 |
| Carvedilol | 100 | $1,445 | $14 |
| Ezetimibe | 14 | $1,412 | $101 |
| Metoprolol | 98 | $1,406 | $14 |
| Isosorbide Dinitrate | 13 | $1,046 | $80 |
| Furosemide | 145 | $1,015 | $7 |
| Spironolactone | 77 | $995 | $13 |
| Clopidogrel | 51 | $992 | $19 |
| Klor-Con M20 | 16 | $907 | $57 |
| Diltiazem 24hr Er (Xr) | 11 | $855 | $78 |
| Hydralazine | 21 | $694 | $33 |
| Atenolol | 37 | $679 | $18 |
| Dilt-Xr | 15 | $635 | $42 |
| Digoxin | 25 | $632 | $25 |
| Nitroglycerin | 35 | $583 | $17 |
| Diltiazem 24hr Er | 23 | $559 | $24 |
| Warfarin | 27 | $558 | $21 |
| Klor-Con M10 | 11 | $503 | $46 |
| Tiadylt Er | 15 | $441 | $29 |
| Diltiazem | 13 | $359 | $28 |
| Metolazone | 17 | $345 | $20 |
| Simvastatin | 35 | $304 | $9 |
| Hydrochlorothiazide | 41 | $194 | $5 |
| Triamterene-Hydrochlorothiazid | 11 | $177 | $16 |
2021: 35 drugs
| Eliquis | 458 | $493,888 | $1,078 |
| Xarelto | 97 | $130,462 | $1,345 |
| Metoprolol | 725 | $24,318 | $34 |
| Entresto | 18 | $14,175 | $788 |
| Flecainide Acetate | 83 | $8,890 | $107 |
| Rosuvastatin | 178 | $7,775 | $44 |
| Torsemide | 380 | $7,687 | $20 |
| Atorvastatin | 302 | $5,110 | $17 |
| Potassium Chloride | 79 | $4,334 | $55 |
| Amiodarone | 107 | $4,009 | $37 |
| Diltiazem 24hr Er (Cd) | 41 | $2,994 | $73 |
| Sotalol | 119 | $2,977 | $25 |
| Losartan | 154 | $2,928 | $19 |
| Lisinopril | 226 | $2,690 | $12 |
| Metoprolol | 130 | $1,843 | $14 |
| Isosorbide Mononitrate Er | 85 | $1,771 | $21 |
| Carvedilol | 106 | $1,764 | $17 |
| Amlodipine Besylate | 121 | $1,414 | $12 |
| Clopidogrel | 61 | $986 | $16 |
| Furosemide | 159 | $968 | $6 |
| Klor-Con M20 | 11 | $864 | $79 |
| Nitroglycerin | 58 | $817 | $14 |
| Spironolactone | 87 | $809 | $9 |
| Atenolol | 43 | $757 | $18 |
| Hydralazine | 37 | $682 | $18 |
| Bumetanide | 12 | $591 | $49 |
| Digoxin | 11 | $482 | $44 |
| Warfarin | 28 | $410 | $15 |
| Diltiazem 24hr Er | 12 | $341 | $28 |
| Simvastatin | 15 | $210 | $14 |
| Pravastatin | 12 | $205 | $17 |
| Lovastatin | 11 | $181 | $16 |
| Hydrochlorothiazide | 41 | $142 | $3 |
| Fluticasone Propionate | 15 | $103 | $7 |
| Omeprazole | 11 | $50 | $5 |
2020: 33 drugs
| Eliquis | 214 | $219,973 | $1,028 |
| Xarelto | 73 | $83,752 | $1,147 |
| Metoprolol | 477 | $17,392 | $36 |
| Rosuvastatin | 123 | $6,617 | $54 |
| Atorvastatin | 291 | $5,981 | $21 |
| Torsemide | 289 | $5,748 | $20 |
| Amiodarone | 72 | $3,592 | $50 |
| Potassium Chloride | 70 | $3,443 | $49 |
| Losartan | 169 | $3,283 | $19 |
| Flecainide Acetate | 38 | $3,005 | $79 |
| Isosorbide Mononitrate Er | 95 | $2,152 | $23 |
| Lisinopril | 203 | $1,808 | $9 |
| Midodrine | 11 | $1,706 | $155 |
| Sotalol | 56 | $1,624 | $29 |
| Carvedilol | 99 | $1,604 | $16 |
| Metoprolol | 130 | $1,398 | $11 |
| Clopidogrel | 86 | $1,258 | $15 |
| Nitroglycerin | 80 | $1,240 | $16 |
| Amlodipine Besylate | 96 | $1,033 | $11 |
| Furosemide | 164 | $1,011 | $6 |
| Diltiazem 24hr Er (Cd) | 17 | $840 | $49 |
| Cilostazol | 20 | $792 | $40 |
| Spironolactone | 69 | $724 | $10 |
| Digoxin | 14 | $667 | $48 |
| Cartia Xt | 13 | $553 | $43 |
| Atenolol | 37 | $505 | $14 |
| Warfarin | 21 | $427 | $20 |
| Hydralazine | 18 | $351 | $20 |
| Simvastatin | 18 | $277 | $15 |
| Fluticasone Propionate | 17 | $229 | $13 |
| Metolazone | 11 | $213 | $19 |
| Hydrochlorothiazide | 40 | $207 | $5 |
| Omeprazole | 16 | $104 | $6 |
2019: 36 drugs
| Eliquis | 177 | $137,461 | $777 |
| Xarelto | 75 | $52,962 | $706 |
| Metoprolol | 390 | $14,071 | $36 |
| Repatha Sureclick | 12 | $11,961 | $997 |
| Brilinta | 20 | $9,886 | $494 |
| Rosuvastatin | 164 | $9,722 | $59 |
| Atorvastatin | 305 | $5,906 | $19 |
| Torsemide | 312 | $5,766 | $18 |
| Isosorbide Mononitrate Er | 142 | $3,725 | $26 |
| Potassium Chloride | 41 | $1,931 | $47 |
| Losartan | 134 | $1,867 | $14 |
| Lisinopril | 195 | $1,717 | $9 |
| Clopidogrel | 102 | $1,252 | $12 |
| Cartia Xt | 17 | $1,226 | $72 |
| Carvedilol | 89 | $1,223 | $14 |
| Amlodipine Besylate | 94 | $1,050 | $11 |
| Nitroglycerin | 58 | $976 | $17 |
| Pravastatin | 41 | $962 | $23 |
| Amiodarone | 39 | $931 | $24 |
| Metoprolol | 101 | $931 | $9 |
| Flecainide Acetate | 12 | $867 | $72 |
| Toprol Xl | 14 | $779 | $56 |
| Furosemide | 142 | $720 | $5 |
| Sotalol | 26 | $639 | $25 |
| Spironolactone | 65 | $638 | $10 |
| Diltiazem 24hr Er (Cd) | 14 | $491 | $35 |
| Hydralazine | 18 | $423 | $24 |
| Diltiazem 24hr Er | 13 | $308 | $24 |
| Simvastatin | 34 | $302 | $9 |
| Hydrochlorothiazide | 31 | $295 | $10 |
| Warfarin | 24 | $285 | $12 |
| Metformin Hcl Er | 28 | $235 | $8 |
| Ranitidine | 16 | $194 | $12 |
| Atenolol | 25 | $192 | $8 |
| Omeprazole | 18 | $185 | $10 |
| Diltiazem | 11 | $154 | $14 |
2018: 34 drugs
| Eliquis | 118 | $70,979 | $602 |
| Xarelto | 48 | $29,366 | $612 |
| Metoprolol | 293 | $12,983 | $44 |
| Brilinta | 18 | $9,228 | $513 |
| Rosuvastatin | 81 | $6,279 | $78 |
| Atorvastatin | 154 | $3,336 | $22 |
| Torsemide | 150 | $2,634 | $18 |
| Isosorbide Mononitrate Er | 89 | $2,607 | $29 |
| Potassium Chloride | 34 | $1,335 | $39 |
| Nitroglycerin | 69 | $1,164 | $17 |
| Toprol Xl | 17 | $1,138 | $67 |
| Losartan | 111 | $1,030 | $9 |
| Carvedilol | 92 | $973 | $11 |
| Lisinopril | 114 | $958 | $8 |
| Bumetanide | 11 | $921 | $84 |
| Flecainide Acetate | 15 | $877 | $58 |
| Hydralazine | 23 | $703 | $31 |
| Amlodipine Besylate | 69 | $664 | $10 |
| Clopidogrel | 44 | $541 | $12 |
| Pravastatin | 28 | $508 | $18 |
| Sotalol | 21 | $484 | $23 |
| Furosemide | 94 | $480 | $5 |
| Amiodarone | 23 | $408 | $18 |
| Metoprolol | 50 | $401 | $8 |
| Warfarin | 16 | $390 | $24 |
| Fluticasone Propionate | 17 | $281 | $17 |
| Spironolactone | 33 | $281 | $9 |
| Atenolol | 20 | $251 | $13 |
| Metolazone | 13 | $179 | $14 |
| Simvastatin | 19 | $169 | $9 |
| Hydrochlorothiazide | 28 | $161 | $6 |
| Ranitidine | 13 | $141 | $11 |
| Metformin Hcl Er | 21 | $97 | $5 |
| Omeprazole | 11 | $85 | $8 |
2017: 10 drugs
| Metoprolol | 20 | $960 | $48 |
| Atorvastatin | 31 | $420 | $14 |
| Fluticasone Propionate | 18 | $251 | $14 |
| Lisinopril | 21 | $208 | $10 |
| Losartan | 17 | $205 | $12 |
| Omeprazole | 15 | $170 | $11 |
| Warfarin | 11 | $98 | $9 |
| Furosemide | 19 | $97 | $5 |
| Sertraline | 15 | $90 | $6 |
| Prednisone | 17 | $59 | $3 |
2016: 8 drugs
| Levothyroxine | 20 | $432 | $22 |
| Atorvastatin | 11 | $236 | $21 |
| Lisinopril | 27 | $180 | $7 |
| Azithromycin | 17 | $117 | $7 |
| Prednisone | 28 | $103 | $4 |
| Sertraline | 13 | $91 | $7 |
| Tramadol | 15 | $64 | $4 |
| Furosemide | 12 | $57 | $5 |
2015: 12 drugs
| Metoprolol | 11 | $1,197 | $109 |
| Hydrocodone-Acetaminophen | 16 | $394 | $25 |
| Warfarin | 16 | $357 | $22 |
| Atorvastatin | 16 | $343 | $21 |
| Amoxicillin-Clavulanate Potass | 17 | $268 | $16 |
| Levothyroxine | 13 | $190 | $15 |
| Tramadol | 18 | $149 | $8 |
| Fluconazole | 11 | $146 | $13 |
| Lisinopril | 20 | $118 | $6 |
| Azithromycin | 15 | $115 | $8 |
| Prednisone | 16 | $85 | $5 |
| Ciprofloxacin | 14 | $81 | $6 |
Money from drug and device companies
$87 in 2025
| 2025 | 1 | 1 | None | $87 |
| 2023 | 2 | 2 | None | $268 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Ensite Precision | $87 | 1 payment
|
See the published payment
| Abbott Laboratories | Meals · 2025-09-10 | Ensite Precision | $87 |
See earlier years (2023)
2023: $268
| Boston Scientific | None | $250 | 1 payment
|
| Medtronic | None | $18 | 1 payment
|
Professional record
- NPI
- 1912314097
- Licence
- CA 61255, MN 11679California G61255: Deceased
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X); Physician assistant, medical (363AM0700X)
- Mailing address
- Po Box 860912, Provider Enrollment - Mchs Wi, Minneapolis, MN, 55486
- NPI first listed
- 2014-07-21
- NPI last updated
- 2026-08-24
- NPI record certified
- 2026-08-24
This is when the NPI record was last certified, not a medical board exam.